Didier Surdez Selected Research

Didier Surdez Research Topics

Disease

31	Neoplasms (Cancer) 03/2024 - 03/2012
20	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 11/2010
5	Genetic Translocation (Chromosomal Translocation) 03/2024 - 10/2013
4	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 01/2017
4	Carcinogenesis 03/2024 - 01/2017
4	Neuroblastoma 01/2023 - 09/2017
3	Rhabdomyosarcoma 03/2024 - 01/2020
3	Neoplasm Metastasis (Metastasis) 11/2021 - 10/2019
2	Alveolar Rhabdomyosarcoma 12/2023 - 01/2020
2	Rhabdoid Tumor (Rhabdoid Tumors) 12/2019 - 11/2017
1	Sickle Cell Trait 01/2023
1	Bone Neoplasms (Bone Cancer) 05/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Weight Gain 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Cysts 11/2021
1	Oncogene Addiction 03/2012

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2010
7	Transcription Factors (Transcription Factor)IBA 01/2023 - 10/2013
5	ChromatinIBA 12/2023 - 01/2017
5	EWS-FLI fusion proteinIBA 01/2021 - 10/2013
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2014
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 03/2012
3	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2019
2	Vincristine (Oncovin)FDA LinkGeneric 03/2024 - 01/2023
2	Circulating Tumor DNAIBA 10/2022 - 01/2021
2	Proto-Oncogene Proteins c-etsIBA 05/2022 - 01/2018
2	CohesinsIBA 01/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019 - 07/2016
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2017
1	Phosphotransferases (Kinase)IBA 03/2024
1	bemcentinibIBA 03/2024
1	Axl Receptor Tyrosine KinaseIBA 03/2024
1	Cysteine (L-Cysteine)FDA Link 12/2023
1	PlasticsIBA 10/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	RG7388IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	IronIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2023
1	lorlatinibIBA 01/2023
1	GTP Phosphohydrolases (GTPases)IBA 01/2023
1	Drug CombinationsIBA 01/2023
1	ProteomeIBA 12/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 05/2022
1	Mevalonic Acid (Mevalonate)IBA 05/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022
1	Rosiglitazone (Avandia)FDA Link 01/2022
1	RetinoidsIBA 01/2022
1	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Glutathione (Reduced Glutathione)IBA 11/2021
1	AntibodiesIBA 11/2021
1	SiliconesIBA 06/2021
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	AntigensIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Aurora Kinase AIBA 01/2020
1	navitoclaxIBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	Small Cytoplasmic RNAIBA 12/2019
1	Histone Deacetylase InhibitorsIBA 12/2019
1	entinostat (MS 275)IBA 12/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2019
1	clofiliumIBA 11/2017
1	pazopanib FDA Link 11/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2017
1	Calcibiotic Root Canal SealerIBA 09/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	NucleotidesIBA 11/2014
1	Protein Kinases (Protein Kinase)IBA 09/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2012
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2012

Therapy/Procedure

8	Therapeutics 03/2024 - 03/2012
4	Drug Therapy (Chemotherapy) 03/2024 - 11/2017
3	Precision Medicine 01/2023 - 03/2017
1	Aftercare (After-Treatment) 03/2024
1	Induction Chemotherapy 01/2023
1	Immunotherapy 11/2021
1	Complementary Therapies (Alternative Medicine) 11/2014